Enrico Camporesi1, Giuliano Vezzani2, Vincenzo Zanon2, Daniele Manelli2, Garrett Enten3, Silvia Quartesan2, Gerardo Bosco2. 1. Emeritus Professor of Surgery /Anesthesiology and Molecular Pharmacology / Physiology and TeamHealth Anesthesia Research Institute, University of South Florida, Tampa, Florida. 2. Biomedical Sciences, Universita degli Studi di Padova, Padova, Italy. 3. TeamHealth Anesthesia Research Institute, University of South Florida, Tampa, Florida.
Abstract
BACKGROUND: Femoral head necrosis (FHN) is a common invalidating disease with an unclear etiology and pathophysiology that affects middle-aged people. FHN may lead to joint collapse and require invasive treatments. Because of its clinical and socioeconomic significance, an early diagnosis, staging and appropriate treatment are required. Unfortunately, to date a unique algorithm for the treatment of FHN has not been defined. OBJECTIVE: In this report we summarize the Tenth European Consensus Conference on hyperbaric medicine (April 2016, France), during which experts from Europe revised the list of accepted indications for hyperbaric oxygen (HBO₂) treatment, including FHN. METHODS: In this report all aspects of osteonecrosis discussed during the meeting have been considered: pathophysiology,clinical presentation, standard management, HBO₂ therapy and evidence-based review of its efficacy. All observations are based on a thorough review of the best available research and evidence-based medicine. CONCLUSIONS: The Consensus Conference in Lille established FHN as an indication for HBO₂ therapy and suggested a protocols guideline to adopt for this pathology.
BACKGROUND:Femoral head necrosis (FHN) is a common invalidating disease with an unclear etiology and pathophysiology that affects middle-aged people. FHN may lead to joint collapse and require invasive treatments. Because of its clinical and socioeconomic significance, an early diagnosis, staging and appropriate treatment are required. Unfortunately, to date a unique algorithm for the treatment of FHN has not been defined. OBJECTIVE: In this report we summarize the Tenth European Consensus Conference on hyperbaric medicine (April 2016, France), during which experts from Europe revised the list of accepted indications for hyperbaric oxygen (HBO₂) treatment, including FHN. METHODS: In this report all aspects of osteonecrosis discussed during the meeting have been considered: pathophysiology,clinical presentation, standard management, HBO₂ therapy and evidence-based review of its efficacy. All observations are based on a thorough review of the best available research and evidence-based medicine. CONCLUSIONS: The Consensus Conference in Lille established FHN as an indication for HBO₂ therapy and suggested a protocols guideline to adopt for this pathology.
Entities:
Keywords:
HBO₂ therapy; avascular head necrosis; femoral head necrosis; osteonecrosis of the femoral head
Authors: Daniel Popa; Anthony Medak; Walter Chin; Oswaldo Huchim-Lara; Evelyne Fliszar; Tudor Hughes; Ian Grover Journal: Diving Hyperb Med Date: 2020-12-20 Impact factor: 0.887
Authors: Jorge Arias-de la Torre; Elisa Puigdomenech; Xavier García; Jose M Valderas; Francisco Jose Eiroa-Orosa; Tania Fernández-Villa; Antonio J Molina; Vicente Martín; Antoni Serrano-Blanco; Jordi Alonso; Mireia Espallargues Journal: J Med Internet Res Date: 2020-08-26 Impact factor: 5.428
Authors: Emma Paderno; Vincenzo Zanon; Giuliano Vezzani; Tommaso Antonio Giacon; Thomas L Bernasek; Enrico M Camporesi; Gerardo Bosco Journal: Int J Environ Res Public Health Date: 2021-03-12 Impact factor: 3.390